Unknown

Dataset Information

0

MiR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis.


ABSTRACT: Glucocorticoid (GC) hormones are an important ingredient of leukemia therapy since they are potent inducers of lymphoid cell apoptosis. However, the development of GC resistance remains an obstacle in GC-based treatment. In the present investigation we found that miR-103 is upregulated in GC-sensitive leukemia cells treated by the hormone. Transfection of GC resistant cells with miR-103 sensitized them to GC induced apoptosis (GCIA), while miR-103 sponging of GC sensitive cells rendered them partially resistant. miR-103 reduced the expression of cyclin dependent kinase (CDK2) and its cyclin E1 target, thereby leading to inhibition of cellular proliferation. miR-103 is encoded within the fifth intron of PANK3 gene. We demonstrate that the GC receptor (GR) upregulates miR-103 by direct interaction with GC response element (GRE) in the PANK3 enhancer. Consequently, miR-103 targets the c-Myc activators c-Myb and DVL1, thereby reducing c-Myc expression. Since c-Myc is a transcription factor of the miR-17~92a poly-cistron, all six miRNAs of the latter are also downregulated. Of these, miR-18a and miR-20a are involved in GCIA, as they target GR and BIM, respectively. Consequently, GR and BIM expression are elevated, thus advancing GCIA. Altogether, this study highlights miR-103 as a useful prognostic biomarker and drug for leukemia management in the future.

SUBMITTER: Kfir-Erenfeld S 

PROVIDER: S-EPMC5352135 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis.

Kfir-Erenfeld Shlomit S   Haggiag Noa N   Biton Moshe M   Stepensky Polina P   Assayag-Asherie Nathalie N   Yefenof Eitan E  

Oncotarget 20170101 1


Glucocorticoid (GC) hormones are an important ingredient of leukemia therapy since they are potent inducers of lymphoid cell apoptosis. However, the development of GC resistance remains an obstacle in GC-based treatment. In the present investigation we found that miR-103 is upregulated in GC-sensitive leukemia cells treated by the hormone. Transfection of GC resistant cells with miR-103 sensitized them to GC induced apoptosis (GCIA), while miR-103 sponging of GC sensitive cells rendered them par  ...[more]

Similar Datasets

| S-EPMC1218274 | biostudies-other
| S-EPMC8369758 | biostudies-literature
| S-EPMC6278493 | biostudies-literature
| S-EPMC9549132 | biostudies-literature
| S-EPMC4729832 | biostudies-other
| S-EPMC7294572 | biostudies-literature
| S-EPMC8917307 | biostudies-literature
| S-EPMC3897649 | biostudies-literature
2012-09-20 | E-GEOD-40642 | biostudies-arrayexpress
| S-EPMC5810201 | biostudies-literature